The Health Corporation - Rambam

Where the EU money came from

Funding by EU programme. Amounts are The Health Corporation - Rambam's own share of each project, not the project's full budget.

Projects

9 EU-funded projects, newest first. The Health Corporation - Rambam led 2 of them as coordinator. Each links to the official record.

• GLIOMATCHPartner

  The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics

  Horizon Europe · 2024–2028 · Project on CORDIS ↗

  €208ktheir share
• RELEVIUMPartner

  Improving quality of life of advanced pancreatic cancer patients through an AI-guided multimodal intervention, combining pain and cachexia management, nutrition, and physical activity

  Horizon Europe · 2022–2026 · Project on CORDIS ↗

  €281ktheir share
• PROFIDPartner

  Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  €185ktheir share
• VALUE-DxPartner

  The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use

  Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  €88ktheir share
• COMBACTE-CAREPartner

  Combatting Bacterial Resistance in Europe - Carbapenem Resistance

  FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗

  €522ktheir share
• PASCALCoordinator

  Pax8 as a marker of Ovarian cancer Originating in the Fallopian tube

  FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

  €100ktheir share
• ENIGMACoordinator

  Enigma – Histone Deacetylase protein complex controls cardiac hypertrophy

  FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

  €100ktheir share
• ABIRISKPartner

  Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk

  FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  €152ktheir share
• AIDAPartner

  Preserving old antibiotics for the future : assessment of clinical efficacy by a pharmacokinetic/pharmacodynamic approach to optimize effectiveness and reduce resistance for off-patent antibiotics

  FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

  €465ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
• The University of EdinburghUnited Kingdom · 2 shared projects
• Uppsala UniversitetSweden · 2 shared projects
• The University of ManchesterUnited Kingdom · 2 shared projects
• Universitair Medisch Centrum UtrechtNetherlands · 2 shared projects
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 2 shared projects
• Universiteit AntwerpenBelgium · 2 shared projects
• Universite de GeneveSwitzerland · 2 shared projects
• Ethniko Kai Kapodistriako Panepistimio AthinonGreece · 2 shared projects
• Academisch Ziekenhuis GroningenNetherlands · 2 shared projects
• Heinrich-Heine-Universitaet DuesseldorfGermany · 2 shared projects
• Academisch Medisch Centrum Bij de Universiteit van AmsterdamNetherlands · 2 shared projects
• The Foundation for Medical Research Infrastructural Development and Health Services Next To the Medical Center Tel AvivIsrael · 2 shared projects
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 2 shared projects
• Pfizer LimitedUnited Kingdom · 2 shared projects
• Centre National de la Recherche Scientifique CNRSFrance · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• antibiotic resistance
• antibiotics
• bacteriology
• cardiology
• cell biology
• databases
• enzymes
• epidemics prevention
• gastroenterology
• immunisation
• immunotherapy
• molecular biology
• multidrug resistance